New foam could ease painful skin bumps
NCT ID NCT07263230
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 2 times
Summary
This study tests a medicated foam (roflumilast) applied to the skin for hidradenitis suppurativa, a condition causing painful bumps and abscesses. About 20 adults with mild to moderate HS will use the foam for 16 weeks. The goal is to see if it reduces the number of inflamed nodules safely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA (HS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beth Israel Deaconess Medical Center
RECRUITINGBoston, Massachusetts, 02215, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injection tame the painful lumps of hidradenitis suppurativa?
- Can brain scans reveal the hidden toll of hidradenitis suppurativa?
- Could botox calm the painful skin flares of hidradenitis suppurativa?
- Can Real-World data unlock better skin disease care?
- Foam could ease painful skin lumps in hidradenitis suppurativa
- Worldwide study aims to uncover hidden patterns in hidradenitis suppurativa care